The Bits in Bio Podcast podcast

Redefining the Undruggable Through Proximity with Armand Cognetta

0:00
36:23
Rewind 15 seconds
Fast Forward 15 seconds

Armand Cognetta, founder and CEO of General Proximity, joins us to explore how proximity medicine is revolutionizing drug discovery by targeting proteins once considered impossible to drug.

We discuss the evolution beyond PROTACs, being a solo bio-founder in Y Combinator, and Armand's journey from imposter syndrome to raising $16M and winning a $3M ARPA-H grant.

From nearly running out of money to building breakthrough platform technology, Armand shares hard-won lessons on fundraising, team building, and maintaining startup speed in an industry known for decade-long timelines.

More episodes from "The Bits in Bio Podcast"